Skandinaviska Enskilda Banken AB (publ) - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 193 filers reported holding MYRIAD GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q2 2020$1,226,000
-58.4%
108,100
-47.6%
0.01%
-33.3%
Q1 2020$2,950,000
+23.4%
206,200
+134.9%
0.02%
-21.1%
Q4 2019$2,391,000
+3.7%
87,800
+9.1%
0.02%0.0%
Q3 2019$2,305,000
-11.9%
80,500
-14.5%
0.02%
-17.4%
Q2 2019$2,617,000
-20.1%
94,200
-4.6%
0.02%
-23.3%
Q1 2019$3,277,000
+22.8%
98,700
+7.5%
0.03%
+25.0%
Q4 2018$2,669,000
-30.3%
91,800
+10.3%
0.02%
-17.2%
Q3 2018$3,827,000
+39.7%
83,200
+13.5%
0.03%
+26.1%
Q2 2018$2,739,000
-0.9%
73,300
-21.6%
0.02%
-14.8%
Q1 2018$2,763,000
-14.3%
93,500
-0.4%
0.03%
-3.6%
Q4 2017$3,225,000
-36.7%
93,900
-33.3%
0.03%
-39.1%
Q3 2017$5,091,000
+46.6%
140,700
+4.7%
0.05%
+39.4%
Q2 2017$3,473,000
-51.3%
134,400
-63.8%
0.03%
-2.9%
Q1 2017$7,134,000
+92.7%
371,600
+67.3%
0.03%
-22.7%
Q4 2016$3,702,000
-26.0%
222,100
-8.6%
0.04%
-18.5%
Q3 2016$5,001,000
-9.7%
243,000
+34.3%
0.05%
-12.9%
Q2 2016$5,536,000
-9.3%
180,900
+10.9%
0.06%
-8.8%
Q1 2016$6,105,000
-24.6%
163,100
-13.0%
0.07%
-35.2%
Q4 2015$8,093,000187,5000.10%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$90,850,0003.94%
Altium Capital Management LP 221,000$4,016,0001.61%
DISCIPLINED GROWTH INVESTORS INC /MN 1,900,787$34,537,0000.93%
Zebra Capital Management LLC 15,352$279,0000.82%
PFM Health Sciences, LP 1,177,250$21,391,0000.82%
EARNEST PARTNERS LLC 6,462,138$117,417,0000.78%
Glenview Capital Management 1,696,791$30,831,0000.77%
AIMZ Investment Advisors, LLC 42,085$765,0000.37%
Phocas Financial Corp. 127,949$2,325,0000.35%
Redhawk Wealth Advisors, Inc. 34,680$630,0000.29%
View complete list of MYRIAD GENETICS INC shareholders